Halozyme Therapeutics
HALO
#1973
Rank
$5.83 B
Marketcap
$41.90
Share price
0.19%
Change (1 day)
7.49%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2022 (TTM): $0.23 B

According to Halozyme Therapeutics's latest financial reports the company's current earnings (TTM) are $0.23 B. In 2021 the company made an earning of $0.24 B an increase over its 2020 earnings that were of $0.12 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$0.23 B-6.11%
2021$0.24 B92.2%
2020$0.12 B-278.96%
2019-$72.26 M-9.45%
2018-$79.8 M-229.51%
2017$61.61 M-160.48%
2016-$0.11 B216.03%
2015-$32.24 M-52.86%
2014-$68.38 M-18.09%
2013-$83.48 M55.67%
2012-$53.63 M170.3%
2011-$19.84 M-63.44%
2010-$54.26 M-7.19%
2009-$58.46 M15.91%
2008-$50.44 M83.89%
2007-$27.43 M78.1%
2006-$15.41 M16%
2005-$13.28 M45.24%
2004-$9.15 M11602.76%
2003-$0.08 M17.61%
2002-$0.07 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$20.51 B 8,692.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$33.77 B 14,373.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.22 B 2,569.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.45 B 3,952.56%๐Ÿ‡ซ๐Ÿ‡ท France
$1.12 B 381.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-$87.51 M-137.50%๐Ÿ‡บ๐Ÿ‡ธ USA